Large B Cell Lymphoma
Links shared publicly online about this topic
Large B-Cell Lymphoma Prognosis-New large B-cell lymphoma prognosis research...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on December 18, 2009 at 2:01 pm By:
New large B-cell lymphoma prognosis research from St. Vincent's Hospital, Department of...http://bit.ly/5BhrjO
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization
hindawi.com — “Although diffuse large B-cell lymphoma (DLBCL) usually occurs in the lymph nodes, approximately 30–40% of the time it can have an extranodal site of involvement and it can arise in nearly every body site such as intestine, bone, breast, liver, skin, lung, and central nervous system. Muscle involvement of DLBCL is especially uncommon, comprising 0.5% of extranodal NHL. We report a case of a 72-year-old man with extranodal DLBCL of a unique manifestation in the calf muscle, involving predominantly” View full resource at hindawi.com
Most Recently Shared on July 9, 2011 at 11:23 pm By:
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization: We report a case of a 72-year-old man with extranod... http://bit.ly/ng4HWW
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma
medicalnewstoday.com — “Genmab A/S (OMX: GEN) announced today top-line interim results from an initial Phase II single arm open label studyof ofatumumab to evaluate the treatment of relapsed Diffuse Large B-CellLympho” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2010 at 2:00 pm By:
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma http://mnt.to/3HdC #lymphoma #leukemia
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma
bloodjournal.hematologylibrary.org — “Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on January 14, 2012 at 5:37 am By:
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma http://t.co/jAcd7q9Z
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma - MPR
empr.com — “Cell Therapeutics announced that it has initiated its trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).” View full resource at empr.com
Most Recently Shared on March 21, 2011 at 3:41 pm By:
MPR News: Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma: Cell Therap... http://bit.ly/gYTSxS
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma - ONA
oncologynurseadvisor.com — “Cell Therapeutics announced that it has initiated its trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 21, 2011 at 3:11 pm By:
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma http://goo.gl/fb/6TUHg
Large B-Cell Lymphoma Therapy-Research results from University of Paris upda...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on December 16, 2009 at 2:00 pm By:
Research results from University of Paris update understanding of large B-cell lymphoma...http://bit.ly/8WzMfx
Large B-Cell Lymphoma-Studies from Monash University provide new data on lar...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on January 6, 2010 at 2:00 pm By:
Studies from Monash University provide new data on large B-cell lymphoma...http://www.newsrx.com/health-articles/1726119.html
Diffuse large B-cell lymphoma with lung involvemen... [Dermatol Online J. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 27, 2010 at 10:22 pm By:
Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate.: W... http://bit.ly/dBBpI2
Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma
news-medical.net — “Genmab A/S announced today top-line interim results from an initial Phase II single arm open label study of ofatumumab to evaluate the treatment of relapsed Diffuse Large B-Cell Lymphoma in patients ineligible for or relapsed following a stem cell transplant.” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 7:29 am By:
Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma: Genmab A/... http://bit.ly/aCgSOz
Bill Gates and Schr'dinger co-founder invest in Nimbus to advance large B-cell lymphoma programs
news-medical.net — “Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.” View full resource at news-medical.net
Most Recently Shared on March 11, 2011 at 2:57 pm By:
Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs: Nimbus Discove... http://bit.ly/e8Fnlm
Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma
news-medical.net — “Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.” View full resource at news-medical.net
Most Recently Shared on May 17, 2011 at 3:00 pm By:
Medicare News: Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell L... http://bit.ly/kOQq2J
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on September 14, 2009 at 1:04 pm By:
UK Clinical Trial for Mediastinal B-Cell Lymphoma: http://bit.ly/18gcjD
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage Treatment for Patients With Relapsed Diffuse Large B-Cell Lymphoma - ONA
oncologynurseadvisor.com — “The combination of rituximab plus vinorelbine, ifosfamide, mitoxantrone, and prednisone (R-NIMP) is well tolerated, yields a high complete response rate, and allows for successful mobilization of CD34+ cells in patients with diffuse large B-cell lymphoma (DLBCL) in first relapse, results of a phase 2 study presented at the 52nd American Society of Hematology Annual Meeting and Exposition have found.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 6, 2010 at 4:05 pm By:
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage… http://goo.gl/fb/YCMoS
Arch Dermatol -- A Case of Intravascular Large B-Cell Lymphoma With Atypical Clinical Manifestations and Analysis of CXCL12 and CXCR4 Expression, June 2010, Nakajima et al. 146 (6): 686
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on June 22, 2010 at 9:26 am By:
A Case of Intravascular Large B-Cell Lymphoma With Atypical Clinical Manifestations and Analysis of CXCL12 and CXC... http://bit.ly/cgITxl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
NewsRx Medical News
-
OrganizedWisdom GI
Organizing gastroenterology and digestion resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

